Systolic and diastolic blood pressure, prostate cancer risk, treatment, and survival. The PROCA-life study.

Einar StikbakkeHenrik SchirmerTore KnutsenMartin StøytenTom WilsgaardEdward L GiovannucciAnne McTiernanAnne E EggenHege S HaugnesElin RichardsenInger Thune

Published in: Cancer medicine (2021)

Our results support that systolic and diastolic BP are important factors when balancing disease management in patients with prostate cancer.

Keyphrases

blood pressure
prostate cancer
left ventricular
radical prostatectomy
hypertensive patients
heart rate
heart failure
type diabetes
atrial fibrillation
free survival
insulin resistance
replacement therapy